AI Powered Mapping Technology for Identifying Arrhythmias

The registry is a retrospective and prospective, post-approval, multicenter, single-arm, all-comers registry with two cohorts:

Retrospective Cohort: approximately 60 patients across two sites. Prospective Cohort: approximately 50 patients across two sites. This registry aims to collect real-world data on the clinical utility, safety, and procedural efficiency of vMap-guided ablation procedures.

Retrospective Arm:

Inclusion criteria

• Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
• The patient can provide written informed consent, if applicable.
• The patient is greater than or equal to 18 years old

Prospective Arm:

Inclusion criteria

• Patients who had a standard of care cardiac ablation (de novo or repeat) where the vMap equipment was used.
• The patient can provide written informed consent, if applicable.
• The patient is greater than or equal to 18 years old

Exclusion criteria

Participants who meet any one of the following criteria will be a screen failure and excluded from participation:

• Non-inducible arrhythmia (unless pre-mapped via vMap prior to the procedure).
• Patients in whom no ablation was performed using the vMap equipment.
• Inability to obtain 12-lead ECG of sufficient quality for vMap analysis.
• In the opinion of the Investigator, the participant is not suitable and has a contraindication to undergo the ablation procedure.